NCT00487695

Brief Summary

The purpose of this study is to determine if confocal laser endomicroscopy (CLE) can improve detection of Barrett's esophagus, dysplasia, and early esophageal cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Apr 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2007

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 19, 2007

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
3 years until next milestone

Results Posted

Study results publicly available

August 17, 2011

Completed
Last Updated

June 22, 2021

Status Verified

June 1, 2021

Enrollment Period

1.1 years

First QC Date

June 18, 2007

Results QC Date

June 21, 2011

Last Update Submit

June 17, 2021

Conditions

Keywords

Barrett's esophagusEsophageal adenocarcinomaEndoscopyConfocal laser endomicroscopy

Outcome Measures

Primary Outcomes (1)

  • Diagnostic Yield for Neoplasia in High Risk Patients(Suspected Neoplasia)

    The yield for neoplasia is calculated by the number of biopsies showing neoplasia over the total number of biopsies taken (normal + neoplastic biopsies)

    6 weeks

Secondary Outcomes (5)

  • Mean Number of Biopsies With Neoplasia in High Risk Patients (Suspected Neoplasia)

    6 weeks

  • Mean Number of Biopsies Taken in High Risk Patients (Suspected Neoplasia)

    6 weeks

  • Diagnostic Yield for Neoplasia in Barrett's Surveillance Patients

    6 weeks

  • Mean Number of Biopsies With Neoplasia in Barrett's Surveillance Patients

    6 weeks

  • Mean Number of Biopsies Taken in Barrett's Surveillance Patients

    6 weeks

Study Arms (2)

CLE followed by standard EGD

ACTIVE COMPARATOR

Participants are randomized to have either confocal laser endomicroscopy (CLE) or standard endoscopy (EGD) first. Then 6 weeks later, they have the other procedure. This arm is for patients randomized to CLE followed by standard EGD

Device: confocal laser endomicroscopy (CLE)Device: standard endoscopy (EGD)

standard EGD followed by CLE

ACTIVE COMPARATOR

Patients are randomized to either have standard endoscopy (EGD)or confocal laser endomicroscopy (CLE) first. The second procedure is then completed 6 weeks later. This arm is for patients who had standard endoscopy first.

Device: confocal laser endomicroscopy (CLE)Device: standard endoscopy (EGD)

Interventions

Confocal laser endomicroscopy is done by performing standard endoscopy, then using a microscope on the tip of the endoscope to obtain microscopic images of the mucosa. This is done by gently placing the tip of the endoscope on the lining of the esophagus.

Also known as: Pentax Confocal Laser Endomicroscope(EC3870KCILK)
CLE followed by standard EGDstandard EGD followed by CLE

Standard upper endoscopy (EGD) is performed using a regular upper endoscope, which is used to look at the lining of the esophagus.

Also known as: Olympus upper endoscope (GIF160)
CLE followed by standard EGDstandard EGD followed by CLE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Barrett's esophagus or suspected Barrett's-associated neoplasia
  • Age \> 18
  • Able to give informed consent

You may not qualify if:

  • Known advanced malignant disease
  • Allergy to the fluorescent contrast agent fluorescein sodium
  • Coagulopathy or bleeding disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Hospital

Baltimore, Maryland, 21205, United States

Location

Related Publications (1)

  • Dunbar KB, Okolo P 3rd, Montgomery E, Canto MI. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc. 2009 Oct;70(4):645-54. doi: 10.1016/j.gie.2009.02.009. Epub 2009 Jun 25.

MeSH Terms

Conditions

Barrett EsophagusAdenocarcinoma Of Esophagus

Interventions

Endoscopy, Digestive System

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Limitations and Caveats

Relatively small study (39 patients) and performed at a tertiary care, referral center, which can reduce generalizability.

Results Point of Contact

Title
Dr. Marcia Canto.
Organization
Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology

Study Officials

  • Marcia I Canto, MD, MHS

    Division of Gastroenterology, Johns Hopkins University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2007

First Posted

June 19, 2007

Study Start

April 1, 2007

Primary Completion

May 1, 2008

Study Completion

September 1, 2008

Last Updated

June 22, 2021

Results First Posted

August 17, 2011

Record last verified: 2021-06

Locations